News
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today a poster presentation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback